A detailed history of Parkman Healthcare Partners LLC transactions in Inari Medical, Inc. stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 77,223 shares of NARI stock, worth $6.18 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
77,223
Previous 44,301 74.31%
Holding current value
$6.18 Million
Previous $1.83 Million 115.88%
% of portfolio
0.57%
Previous 0.26%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$40.61 - $58.21 $1.34 Million - $1.92 Million
32,922 Added 74.31%
77,223 $3.94 Million
Q3 2024

Nov 14, 2024

SELL
$40.68 - $58.62 $6.15 Million - $8.87 Million
-151,266 Reduced 77.35%
44,301 $1.83 Million
Q2 2024

Aug 14, 2024

BUY
$37.11 - $50.69 $2.61 Million - $3.56 Million
70,229 Added 56.03%
195,567 $9.42 Million
Q1 2024

May 15, 2024

BUY
$40.65 - $65.76 $5.09 Million - $8.24 Million
125,338 New
125,338 $6.01 Million

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $4.27B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.